Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Folate Receptor-Alpha Positive”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Early research (Phase 1)Study completedNCT03242993
What this trial is testing

[18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer Imaging

Who this might be right for
Metastatic Cancer LungMetastatic Ovarian Cancer
University of Lausanne Hospitals 15
Testing effectiveness (Phase 2)Study completedNCT03106077
What this trial is testing

Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+18 more
M.D. Anderson Cancer Center 96
Large-scale testing (Phase 3)Study completedNCT03180307
What this trial is testing

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

Who this might be right for
Ovarian Cancer
On Target Laboratories, LLC 140
Testing effectiveness (Phase 2)Looking for participantsNCT04606914
What this trial is testing

Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian TubePrimary Peritoneal Cancer
University of Alabama at Birmingham 70
Early research (Phase 1)WithdrawnNCT05622591
What this trial is testing

ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML

Who this might be right for
Acute Myeloid LeukemiaAML, ChildhoodRelapsed Pediatric AML+1 more
Elucida Oncology
Testing effectiveness (Phase 2)Study completedNCT01689766
What this trial is testing

Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Endocyte 150
Testing effectiveness (Phase 2)Looking for participantsNCT06365853
What this trial is testing

Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression

Who this might be right for
Recurrent Ovarian CancerFolate Receptor-Alpha Positive
AbbVie 100
Early research (Phase 1)Ended earlyNCT02629549
What this trial is testing

Intraoperative Imaging of Pituitary Adenomas by OTL

Who this might be right for
NeoplasmsPituitary Neoplasms
University of Pennsylvania 33
Not applicableUnknownNCT05633680
What this trial is testing

Circulating Tumor Cells Screen for Breast Cancer

Who this might be right for
Breast NeoplasmNeoplastic Cells, Circulating
Handan First Hospital 200
Testing effectiveness (Phase 2)Study completedNCT02606305
What this trial is testing

Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
ImmunoGen, Inc. 264
Testing effectiveness (Phase 2)Active Not RecruitingNCT05456685
What this trial is testing

Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer

Who this might be right for
High Grade Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
AbbVie 125
Testing effectiveness (Phase 2)Looking for participantsNCT05579366
What this trial is testing

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Who this might be right for
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more
Genmab 764
Early research (Phase 1)WithdrawnNCT04941378
What this trial is testing

OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer

Who this might be right for
Ovarian Cancer
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Study completedNCT02317705
What this trial is testing

Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

Who this might be right for
Ovarian Cancer
On Target Laboratories, LLC 48
Testing effectiveness (Phase 2)Study completedNCT01577654
What this trial is testing

Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Endocyte 203
Large-scale testing (Phase 3)Study completedNCT02631876
What this trial is testing

Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer+1 more
ImmunoGen, Inc. 366
Not applicableUnknownNCT04521491
What this trial is testing

A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 184
Testing effectiveness (Phase 2)Looking for participantsNCT03832361
What this trial is testing

Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer

Who this might be right for
Endometrial Cancer
Alessandro Santin 50
Testing effectiveness (Phase 2)Study completedNCT02872701
What this trial is testing

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

Who this might be right for
Lung NeoplasmsLung Cancer
On Target Laboratories, LLC 100
Early research (Phase 1)Study completedNCT01609556
What this trial is testing

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive Solid Tumors

Who this might be right for
Tumors
ImmunoGen, Inc. 206
Load More Results